Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BIND Biosciences Inc Announces Pricing Of Initial Public Offering

Thursday, 19 Sep 2013 07:16pm EDT 

BIND Biosciences Inc announced the pricing of its initial public offering of 4,700,000 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts and commissions. The shares are expected to begin trading on The NASDAQ Global Select Market under the ticker symbol BIND on September 20, 2013. In addition, BIND has granted the underwriters a 30-day option to purchase up to an additional 705,000 shares of common stock at the same price to cover over-allotments, if any. The offering is expected to close on September 25, 2013, subject to customary closing conditions. Credit Suisse (USA) LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. Stifel Nicolaus & Company, Incorporated and JMP Securities LLC are acting as co-managers. 

Company Quote

0.09 +2.07%
27 Aug 2015